IMMUNOPATHOGENESIS OF HEART FAILURE IN PATIENTS WITH INFECTIVE-IMMUNE MYOCARDITIS

IMMUNOPATHOGENESIS OF HEART FAILURE IN PATIENTS WITH INFECTIVE-IMMUNE MYOCARDITIS

Aim. To study quantitative parameters, specifics of functional state of the main subpopulations of peripheral blood lymphocytes of the infective-immune myocarditis patients (IIM) and postmyocarditis cardiosclerosis (PMC), and specifics of cytokine profile.Material and methods. Totally, 35 IIM patien...

Full description

Bibliographic Details
Main Authors:	F. N. Paleev, N. P. Sanina, A. I. Makarkov, N. N. Khishova, O. V. Moskaletz, N. R. Paleev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-01-01
Series:	Российский кардиологический журнал
Subjects:	infective-immune myocarditis postmyocarditis cardiosclerosis lymphocytes immune activation
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/632

Similar Items

CYTOKINE PROFILE OF Th1-, Th2- AND Th17-LYMPHOCYTE SUBPOPULATIONS IN INFECTIOUS MYOCARDITIS
by: N. P. Sanina, et al.
Published: (2016-02-01)

MODERN METHODS OF INTRACARDIAC HEMODYNAMICS AND CARDIAC DEFORMABILITY ASSESSMENT IN PREGNANT WOMEN WITH DILATION CARDIOMYOPATHY SYNDROME
by: D. A. Doroshenko, et al.
Published: (2016-04-01)

THE EVOLUTION OF UNDERSTANDING OF THE IMMUNE SYSTEM'S ROLE IN THE PATHOGENESIS OF INFLAMMATORY MYOCARDIAL DISEASES: TH17-MEDIATED IMMUNE MECHANISMS
by: N. R. Paleev, et al.
Published: (2014-02-01)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
by: Zsofia D. Drobni, et al.
Published: (2020-12-01)

Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications
by: Chun-Ka Wong, et al.
Published: (2023-01-01)

Immune mechanisms of group B coxsackievirus induced viral myocarditis
by: Yue Zhang, et al.
Published: (2023-12-01)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
by: Nicolas Palaskas, et al.
Published: (2020-01-01)

Fetal myocarditis – a precursor of undesirable consequences of intrauterine infection with parvovirus B19
by: N. P. Bondarenko, et al.
Published: (2019-05-01)

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
by: Muhammet Gürdoğan, et al.
Published: (2020-07-01)

Controversial and open issues of diagnosis and treatment of myocarditis (based on the discussion of Russian national recommendations)
by: O. V. Blagova, et al.
Published: (2021-12-01)

Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
by: Whitney Barham, et al.
Published: (2021-02-01)

Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
by: Xin Zhang, et al.
Published: (2023-01-01)

The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond
by: Dan Gilon, et al.
Published: (2022-02-01)

Myocarditis as a cause of chronic heart failure
by: E. V. Filippov
Published: (2018-09-01)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
by: Osnat Itzhaki Ben Zadok, MD, MS, et al.
Published: (2019-09-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
by: Mariana Mirabel, MD, PhD, et al.
Published: (2020-09-01)

Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
by: Michael P. O’Shea, et al.
Published: (2023-09-01)

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
by: Yuxiao Hu, et al.
Published: (2021-12-01)

Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
by: Valentina A. Rossi, et al.
Published: (2023-08-01)

Clinical outcome of acute myocarditis in children according to treatment modalities
by: Hyun Jung Kim, et al.
Published: (2010-07-01)

SUBPOPULATIONAL FEATURES OF PERIPHERAL BLOOD CELLS IN THE PATIENTS WITH AUTOIMMUNE MYOCARDITIS: CLINICAL AND PATHOGENETIC ASPECTS
by: N. N. Kekenadze, et al.
Published: (2014-07-01)

SUBPOPULATIONAL FEATURES OF PERIPHERAL BLOOD CELLS IN THE PATIENTS WITH AUTOIMMUNE MYOCARDITIS: CLINICAL AND PATHOGENETIC ASPECTS
by: N. N. Kekenadze, et al.
Published: (2014-07-01)

Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop
by: Daniela Čiháková, et al.
Published: (2022-09-01)

Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure
by: Colton R. Martens, et al.
Published: (2021-09-01)

Multiple Sclerosis: New Aspects of Immunopathogenesis
by: Ines Lazibat, et al.
Published: (2018-01-01)

Heart remodeling in patients with post-infarction cardiosclerosis at various stages of chronic heart failure
by: V. V. Masur, et al.
Published: (2008-06-01)

Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy
by: Zhe Lei, et al.
Published: (2024-02-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors
by: Roberta Esposito, et al.
Published: (2021-05-01)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
by: Kasper Favere, et al.
Published: (2021-05-01)

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
by: Yanna Lei, et al.
Published: (2022-07-01)

Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis
by: Jun Shao, et al.
Published: (2023-12-01)

Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib
by: Qian Xing, et al.
Published: (2022-09-01)

Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
by: Jesus Jimenez, et al.
Published: (2023-03-01)

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
by: Feifei Wang, et al.
Published: (2021-07-01)

Acute lymphocytic myocarditis presenting as complete heart block in an adult: a case report
by: Thomas Camilleri, et al.
Published: (2023-08-01)

Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
by: Hu Chunhong, et al.
Published: (2022-12-01)

Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge
by: Federica Frascaro, et al.
Published: (2023-12-01)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
by: Inês Teixeira Farinha, et al.
Published: (2016-11-01)

TRANSPLANTED HEART. RIGHT VENTRICULAR FAILURE, REJECTION OR MYOCARDITIS?
by: E. N. Ostroumov, et al.
Published: (2011-06-01)